Category: Biotechnology
Biotechnology market research reports by FirstWord
-
RWE in Gene Therapy: Payer Views
RWE in Gene Therapy: Payer Views How to harness RWE to win payer support for gene therapies Gene therapy developers are looking beyond rare diseases to treat a broader range of conditions. While payers are positive for new therapies that treat unmet clinical need there is a growing anxiety: can the ... Read More
-
Applying AI to Drug Discovery and Development: Issues and Challenges
Applying AI to Drug Discovery and Development: Issues and Challenges Pharma has invested heavily in Artificial Intelligence (AI) enabled technologies in the hope they would drive R&D efficiency gains. From identifying new targets and making screening more efficient to de-risking and accelerating cli ... Read More
-
Advances in Wearable Health Technology
Advances in Wearable Health Technology With the roll out of 5G, increasingly sophisticated biosensor technologies and the establishment of digital biomarkers, wearables are expanding into clinical settings. How–and where–can pharma benefit? In what ways can wearables be used to improve patient adher ... Read More
-
Cell and Gene Therapies: Accelerating uptake
Cell and Gene Therapies: Accelerating uptake Cell and gene therapies (CAGTs) are delivering on the promise of personalised medicines, meeting high unmet need and delivering powerful and curative treatments. So why is uptake so slow? The obstacles are diverse with the low volume of patients impacting ... Read More
-
Medical Launch Readiness in a Virtual World
Medical Launch Readiness in a Virtual World From RWE generation to the delivery of personalised medical information, digital technology is enabling medical affairs to take a central role in product launch preparation. But is pharma getting full value from its medical affairs team? Why should medical ... Read More
-
Digital Twins: Trends and Opportunities
Digital Twins: Trends and Opportunities Second generation digital twins have the potential to transform pharma’s business, clinical research and manufacturing processes while driving the personalised medicine agenda and improving chronic disease diagnosis. But can developers overcome significant cha ... Read More
Research Assistance
